Asia’s arms race shift: India climbs, China slides on PLA graft charges

Global arms revenues hit a record $679 billion in 2024 (up 5.9% in real terms) driven by US and European firms while Asia/Oceania declined. India’s three Top‑100 firms saw combined arms revenue rise 8.2% to $7.5 billion (BEL $2.47bn, +24%; HAL $3.81bn, -0.3%; Mazagon Dock $1.23bn, +9.8%), whereas China’s eight Top‑100 companies fell 10% to $88.3 billion (NORINCO -31%, CASC -16%, AVIC -1.3%) amid corruption probes and contract delays. Major US primes generated $334 billion (39 firms; Lockheed Martin $64.7bn) but face program delays and cost overruns (F‑35 delivery delays ~238 days avg; lifetime sustainment ~$1.6tn; Northrop Sentinel cost growth ~80%), while Europe (+13% to $151bn), Russia ($31.2bn, +23%) and Middle Eastern firms (+14% to $31bn; Israel $16.2bn, +16%) show divergent regional trajectories, implying shifting procurement risks and opportunities for defense suppliers and sovereign buyers.

Analysis

Market structure: The report reallocates marginal share toward US, Europe, Japan, Korea and Israel while China’s state-heavy producers underperformed; expect pricing power to rise for niche exporters (missiles, air defenses, uncrewed systems) where supply is concentrated. India’s steady +8.2% gain is incremental but meaningful—over 3–5 years it can displace low-end imports in Africa/SE Asia and compress margins of incumbents there. Elevated global defense spend (Top100 $679bn) points to durable topline growth but selective capacity constraints (munitions, specialty semiconductors, shipyards) will create wedge pricing in 6–24 months.

Risk assessment: Tail risks include a major geopolitical shock (Taiwan/Gaza escalation) that could lift defense equities +30% in weeks or, conversely, US budget cuts/audit findings that cancel large programs (F‑35/Columbia/Sentinel) trimming revenues 10–20% for affected primes. Short-term (days–weeks) volatility will cluster around budget announcements and SIPRI/DoD revelations; medium-term (3–12 months) depends on contract awards and Chinese political stabilization. Hidden dependencies: export controls, semiconductor supply, and foreign-currency financing for buyer nations—watch munitions commodity tightness and Chinese procurement calendar.

Trade implications: Favor high-quality backlog and lower program execution risk—overweight RTX and GD relative to LMT and NOC; consider 6–12 month directional and relative-value trades (see decisions). Options should be used to define downside on LMT/NOC and to buy upside convexity into RTX/GD ahead of budget/award catalysts. Rotate 1–3% of portfolio into munitions/steel/semiconductor suppliers for supply-chain exposure; reduce cyclicals dependent on Chinese orders.

Contrarian angles: Consensus overweights the China-recovery narrative; the data suggests a 6–18 month window where non‑Chinese exporters can capture share—this is underpriced. Conversely the market may be over-penalizing US primes like Lockheed given enormous backlog; a disciplined buyback/contractual structure could limit downside. Historical parallel: post-program purges (1990s/2000s) temporarily depressed cover ratios but eventual recovery followed once procurement integrity was restored. Unintended consequence: sustained re-shoring increases unit costs and compresses long-run margins for primes if governments demand domestic content.

Key Decisions for Investors

• Establish a 2.5% portfolio long in RTX (RTX) with 9–12 month horizon; target +20% upside by next fiscal cycle driven by resilience and services exposure. Place stop-loss at -12% and trim to half at +12% near DoD contract announcements.
• Implement a dollar‑neutral pair trade: Long RTX 2.0% vs Short LMT 2.0% (1:1 notional) with 6–9 month horizon to capture execution risk differential. Close if relative performance diverges by 10% or after US FY2026 defense topline release.
• Purchase a protective 6‑month put spread on NOC (buy 1x 10% OTM put / sell 1x 25% OTM put) sized to 1% portfolio to express downside from Sentinel/time/cost overruns while capping premium outlay.
• Overweight iShares U.S. Aerospace & Defense ETF (ITA) by +1.5% for 3–12 months to capture broad European rearmament and munitions/shipbuilding demand; offset with -1% cash/short small-cap cyclical industrials sensitive to Chinese procurement. Monitor: US DoD budget release (next 30–90 days), major SIPRI/GAO reports, and high‑profile contract awards — any one of these should trigger re‑rating or liquidation rules above.